<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The use of fenoterol in the treatment of <z:e sem="disease" ids="C0022876" disease_type="Disease or Syndrome" abbrv="">preterm labor</z:e> is associated with the risk of many complications in the mother and the fetus </plain></SENT>
<SENT sid="1" pm="."><plain>We present a case of a multipara treated with oral fenoterol due to threatening <z:e sem="disease" ids="C0022876" disease_type="Disease or Syndrome" abbrv="">preterm labor</z:e> 14 weeks </plain></SENT>
<SENT sid="2" pm="."><plain>At 35 weeks of gestation the fetus was diagnosed with <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> with severe impairment of the right ventricle </plain></SENT>
<SENT sid="3" pm="."><plain>The only factor that might have caused such a state of the fetal circulatory system was fenoterol, used from 21 weeks of gestation </plain></SENT>
<SENT sid="4" pm="."><plain>After the withdrawal of the fenoterol the fetal right ventricular function improved gradually </plain></SENT>
<SENT sid="5" pm="."><plain>However fetal <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp> persisted until the birth at 39 weeks of gestation </plain></SENT>
<SENT sid="6" pm="."><plain>Concentric <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> of the right ventricular wall and interventricular septum were confirmed in the newborn </plain></SENT>
</text></document>